Survival of lung metastasis of follicular thyroid cancer is related to patient’s age, physical condition, treatment means and recovery.
Thyroid follicular carcinoma is a common type of thyroid malignant tumor with low degree of pathological malignancy, and it mostly reaches the lungs through hematogenous metastasis.
After diagnosis, most of the early stage patients can be completely cured by radical surgery, and there is no need for adjuvant treatments such as radiotherapy and chemotherapy after surgery, and the survival rate of 10 years can reach more than 90%. After surgery, patients with intermediate stage follicular thyroid cancer need chemotherapy, radiotherapy and targeted drug therapy to control the disease and prevent recurrence, and the 5-year survival rate is about 70%.
If thyroid follicular carcinoma has lung metastasis, it means that the patient has already reached the middle or late stage, and the life span can be prolonged by 1-3 years if actively treated. After diagnosis, surgical resection (total thyroidectomy with lymph node dissection) is needed, and iodine 131 treatment and levothyroxine maintenance therapy are also needed after the surgery.